OTCPK:QMED

Stock Analysis Report

Executive Summary

QMed, Inc. does not have significant operations.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • QMed's last earnings update was 4166 days ago.
  • QMed is not covered by any analysts.
  • QMed is a small market cap stock, these often have low liquidity.

Share Price & News

How has QMed's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:QMED

1.3%

US Healthcare

1.2%

US Market


1 Year Return

-99.0%

OTCPK:QMED

-8.2%

US Healthcare

1.7%

US Market

QMED underperformed the Healthcare industry which returned -8.2% over the past year.

QMED underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

QMEDIndustryMarket
7 Day0%1.3%1.2%
30 Day0%-0.7%4.9%
90 Dayn/a0.01%3.7%
1 Year-99.0%-99.0%-6.8%-8.2%3.9%1.7%
3 Yearn/a30.1%24.9%47.2%37.7%
5 Year-99.0%-99.0%63.5%53.8%60.0%42.4%

Price Volatility Vs. Market

How volatile is QMed's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is QMed undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether QMed is trading at an attractive price based on the cash flow it is expected to produce in the future. But as QMed has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine QMed's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through QMed regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is QMed expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as QMed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Examine QMed's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access QMed's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has QMed performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, QMed has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is QMed's financial position?


In this section we usually analyse QMed's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. QMed has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of QMED’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when QMed's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is QMed's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate QMed's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate QMed's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as QMed has not reported any payouts.

Unable to verify if QMed's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as QMed has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of QMed's salary, the management and board of directors tenure and is there insider trading?

17.7yrs

Average management tenure


CEO

Jane Murray (56yo)

0yrs

Tenure

US$285,065

Compensation

Ms. Jane A. Murray has been the Chief Operating Officer QMed Inc., since January 1, 2002, President since November 28, 2006 and also serves as its Chief Executive Officer. Ms. Murray served as Executive Vi ...


Management Age and Tenure

17.7yrs

Average Tenure

63yo

Average Age

The average tenure for the QMed management team is over 5 years, this suggests they are a seasoned and experienced team.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Michael Cox (77yo)

    Founder and Special Advisor

    • Tenure: 12.8yrs
    • Compensation: US$1.31m
  • Richard Levin (70yo)

    Founder and Director

    • Tenure: 36.7yrs
    • Compensation: US$166.26k
  • Jane Murray (56yo)

    Principal Executive Officer

    • Tenure: 0yrs
    • Compensation: US$285.07k
  • Teri Kraf (69yo)

    Senior Vice President of Health Management Services

    • Tenure: 18.4yrs
    • Compensation: US$217.59k
  • John Siegel (63yo)

    Senior Vice President of Sales & Field Services

    • Tenure: 18.4yrs
    • Compensation: US$228.70k
  • William Schmitt (58yo)

    Chief Financial Officer

    • Tenure: 16.9yrs
    • Compensation: US$233.15k
  • K. Burt (63yo)

    President of Health E Monitoring Inc

    • Tenure: 0yrs

Board Members

  • Richard Levin (70yo)

    Founder and Director

    • Tenure: 36.7yrs
    • Compensation: US$166.26k
  • Jane Murray (56yo)

    Principal Executive Officer

    • Tenure: 0yrs
    • Compensation: US$285.07k

Company Information

QMed, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: QMed, Inc.
  • Ticker: QMED
  • Exchange: OTCPK
  • Founded: 1983
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$17.000
  • Shares outstanding: 17.08m
  • Website: https://www.qmedinc.com

Location

  • QMed, Inc.
  • 25 Christopher Way
  • Eatontown
  • New Jersey
  • 7724
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
QMEDOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 1984

Biography

QMed, Inc. does not have significant operations. Previously, the company was engaged in providing disease management services to health plans and federal government. QMed, Inc. was founded in 1983 and is b ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/14 23:47
End of Day Share Price2019/08/13 00:00
Earnings2008/02/29
Annual Earnings2007/11/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.